Your browser doesn't support javascript.
loading
Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation.
Molofsky, Ari B; Van Gool, Frédéric; Liang, Hong-Erh; Van Dyken, Steven J; Nussbaum, Jesse C; Lee, Jinwoo; Bluestone, Jeffrey A; Locksley, Richard M.
Afiliação
  • Molofsky AB; Department of Microbiology & Immunology, University of California, San Francisco, San Francisco, CA 94143-0795, USA; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143-0795, USA.
  • Van Gool F; Diabetes Center, University of California, San Francisco, San Francisco, CA 94143-0795, USA.
  • Liang HE; Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA 94143-0795, USA.
  • Van Dyken SJ; Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA 94143-0795, USA; Department of Microbiology & Immunology, University of California, San Francisco, San Francisco, CA 94143-0795, USA.
  • Nussbaum JC; Department of Medicine, University of California, San Francisco, San Francisco, CA 94143-0795, USA; Department of Microbiology & Immunology, University of California, San Francisco, San Francisco, CA 94143-0795, USA.
  • Lee J; Department of Microbiology & Immunology, University of California, San Francisco, San Francisco, CA 94143-0795, USA.
  • Bluestone JA; Diabetes Center, University of California, San Francisco, San Francisco, CA 94143-0795, USA; Department of Microbiology & Immunology, University of California, San Francisco, San Francisco, CA 94143-0795, USA.
  • Locksley RM; Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA 94143-0795, USA; Department of Medicine, University of California, San Francisco, San Francisco, CA 94143-0795, USA; Department of Microbiology & Immunology, University of California, San Francisco, San F
Immunity ; 43(1): 161-74, 2015 Jul 21.
Article em En | MEDLINE | ID: mdl-26092469
ABSTRACT
Group 2 innate lymphoid cells (ILC2s) and regulatory T (Treg) cells are systemically induced by helminth infection but also sustain metabolic homeostasis in adipose tissue and contribute to tissue repair during injury. Here we show that interleukin-33 (IL-33) mediates activation of ILC2s and Treg cells in resting adipose tissue, but also after helminth infection or treatment with IL-2. Unexpectedly, ILC2-intrinsic IL-33 activation was required for Treg cell accumulation in vivo and was independent of ILC2 type 2 cytokines but partially dependent on direct co-stimulatory interactions via ICOSL-ICOS. IFN-γ inhibited ILC2 activation and Treg cell accumulation by IL-33 in infected tissue, as well as adipose tissue, where repression increased with aging and high-fat diet-induced obesity. IL-33 and ILC2s are central mediators of type 2 immune responses that promote tissue and metabolic homeostasis, and IFN-γ suppresses this pathway, likely to promote inflammatory responses and divert metabolic resources necessary to protect the host.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ativação Linfocitária / Interleucinas / Interferon gama / Infecções por Strongylida / Linfócitos T Reguladores Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ativação Linfocitária / Interleucinas / Interferon gama / Infecções por Strongylida / Linfócitos T Reguladores Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article